Related Experiment Videos
bcl-2 expression in normal breast tissue during the menstrual cycle
J C Sabourin1, A Martin, J Baruch
1Department of Pathology, Henri Mondor Hospital, Créteil, France.
International Journal of Cancer
|October 1, 1994
Summary
Bcl-2 (B-cell lymphoma 2) expression in normal breast tissue shows significant cyclic variation, peaking mid-cycle. This suggests hormone-dependent regulation, potentially impacting breast tumorigenesis.
Area of Science:
- Oncology
- Cell Biology
- Endocrinology
Background:
- Bcl-2 (B-cell lymphoma 2) is a proto-oncogene linked to apoptosis regulation.
- Follicular lymphomas often exhibit the t(14;18) translocation involving bcl-2.
- Apoptosis occurs in normal breast epithelial cells, with a peak in the luteal phase.
Purpose of the Study:
- To investigate bcl-2 expression patterns in normal breast tissue throughout the menstrual cycle.
- To determine if bcl-2 expression in breast tissue is influenced by hormonal fluctuations.
Main Methods:
- Immunohistochemical analysis of bcl-2 expression.
- Study conducted on 50 normal breast tissue samples.
- Samples collected across different phases of the menstrual cycle.
Main Results:
- Bcl-2 staining was predominantly observed in lobular epithelial cells.
- A striking cyclic variation in bcl-2 expression was detected.
- Maximal bcl-2 expression occurred at mid-cycle, decreasing sharply by the end of the cycle.
Conclusions:
- Bcl-2 expression in normal breast tissue is hormone-dependent.
- Cyclic regulation of bcl-2 may play a role in breast tumorigenesis.
- Further research into hormonal influence on bcl-2 is warranted.